This research proposal attempts to take advantage of the tremendous biotechnological advancement of the past decade to increase the production of the farm-raised fish by reducing their growth cycle from egg to market size. BioPath attempts to develop an oral delivery system for recombinant salmon growth hormone as an effective alternative to the current methods of parenteral injections (ip or im) and bath immersion. This project deals with basic biochemical and physiological determinants for the transport of intact protein molecules from the gastrointestinal (GI) tract into the circulation, specifically, this project is to examine factors that affect the lymphatic uptake of an intact protein molecule from the GI tract, so the transport of intact protein molecule can be enhanced. They can thus modify the protein molecule accordingly. In this proposal, they propose to utilize the whole fish gut instead of the second intestinal segment of an agastric fish (or its equivalent of a gastric fish) for protein transport by modifying the protein molecule in such a way that its absorption in the GI tract mimics the fat absorption in fish.

Agency
National Science Foundation (NSF)
Institute
Division of Industrial Innovation and Partnerships (IIP)
Type
Standard Grant (Standard)
Application #
9460944
Program Officer
F.C. Thomas Allnutt
Project Start
Project End
Budget Start
1995-02-01
Budget End
1995-11-30
Support Year
Fiscal Year
1994
Total Cost
$65,000
Indirect Cost
Name
Biopath Inc
Department
Type
DUNS #
City
Redmond
State
WA
Country
United States
Zip Code
98052